CAI: CAI International, Inc. - Summary | Jitta
Jitta Wealth
NEW
Log in
Sign up
×
Log in

CAI International, Inc.

NYSE:CAI

SummaryFactSheetFinancial
Price
$14.55
Loss Chance
49.2%
4.74JITTA SCORE
221.41%Over Jitta Line
Jitta Ranking
Biotechnology
30 / 280
Health Care
134 / 718
United States
?
1,502 / 4,227
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Related
Aurinia Pharmaceuticals
NASDAQ:AUPH
5.68
$15.28
38.90%
Aurinia Pharmaceuticals
NASDAQ:AUPH
5.68
$15.28
38.90%
Compugen Ltd.
NASDAQ:CGEN
4.58
$2.75
56.61%
Catalyst Pharmaceuticals
NASDAQ:CPRX
6.36
$31.18
42.84%
Exelixis
NASDAQ:EXEL
6.93
$50.13
32.15%
Jitta Factors
Growth Opportunity (60)
Recent Business Performance (76)
Financial Strength (41)
Return to Shareholders (12)
Competitive Advantage (61)
Jitta Signs
Recent Business PerformanceEarning Growth Last Year
Recent IPOLess than 3 years
Key Stats
Jitta Score
Jitta Line
4.74
221.41%
2.22
136.15%
3.06
202.58%
Biotechnology
5.68
38.90%
5.68
38.90%
4.58
56.61%
COMPANY DESCRIPTION
Caris Life Sciences, Inc., an artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally. It develops and commercializes solutions to transform healthcare using molecular information, and artificial intelligence/machine learning algorithms. The company’s molecular intelligence product portfolio includes MI Profile Platform, a whole exome sequencing (WES)/ whole transcriptome sequencing (WTS) tissue-based molecular profiling solutions; Caris Assure Platform WES/WTS blood-based molecular profiling solutions; Precision Whole Genome Platform, a whole genome sequencing (WGS) blood- and tissue-based profiling solutions; and Caris Detect, a WGS-based multi-cancer early detection solution; Caris WGS MRD a WGS and digital droplet polymerase reaction-based minimal residual disease solution; and Caris ChromoSeq, a WGS and WTS based assay for therapy selection in hematological cancers. It also offers pharma research and development services comprising laboratory delivery, strategic data, and research services to biopharmaceutical customers. The company provides its precision oncology solutions to customers, such as hospitals, institutions and patients. The company was founded in 2008 and is headquartered in Irving, Texas.
www.carislifesciences.com
About UsCareersHelp CenterLibraryTermsPrivacyContact UsPress

Jitta Dot Com Co., Ltd. is the owner of the copyright of JITTA SCORE, JITTA LINE, JITTA SIGNS, JITTA FACTORS, JITTA LOSS CHANCE and JITTA RANKING. By accessing or using Jitta, you agree to comply with our Terms of Use and agree not to redistribute the information.

All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Any historical returns, backtest statistics or probability projections may not reflect future performance. Neither Jitta nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Fundamental data of companies, historical data, daily updates, financial statements, dividend data and index data are provided by S&P Global Market Intelligence. All stock prices are updated at the end of the day.